Results 131 to 140 of about 93,843 (327)

Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). VI. T cell fine specificity. [PDF]

, 1985
David R. Milich, D L Peterson, Geert Leroux‐Roels, R.A. Lerner, Francis V. Chisari   +4 more
openalex   +1 more source

Dried Blood Spots and Plasma Separation Cards can Broaden Access to Molecular Testing for HBV, HCV and HIV

Reviews in Medical Virology, Volume 35, Issue 5, September 2025.
ABSTRACT Approximately 3.5 million people acquired HBV, HCV, or HIV‐1 in 2022, and 340 million persons are infected with at least one of these three viruses, mostly in low‐ and middle‐income countries (LMICs). Nucleic acid amplification tests (NAAT) are precise and sensitive tools for viral infection diagnosis, monitoring and sequencing.
Jeffrey V. Lazarus, Neil Parkin, Huma Qureshi, Benjamin LaBrot, John W. Ward   +4 more
wiley   +1 more source

Localization of HBcAg and HBsAg in the hepatocytes

, 1975
Toshio Shikata, Chiho Yoshizaki, Keikoh Okazaki, T Uzawa, Kazuyuki Matsushita, Takashi Takahashi, S. Kuriyama Y. Toyokawa, Atsushi Gotoh, Nakao Ishida   +8 more
openalex   +2 more sources

Lack Of In Vivo Activation of the Interferon System in Hbsag–Positive Chronic Active Hepatitis [PDF]

, 1985
A Poitrine, S. Chousterman, M Chousterman, Sylvie Naveau, Ming Nguy Thang, Jean‐Claude Chaput   +5 more
openalex   +1 more source

Evaluating the prevalence and severity of metabolic dysfunction‐associated steatotic liver disease in patients with type 2 diabetes mellitus in primary care

Journal of Internal Medicine, Volume 298, Issue 3, Page 173-187, September 2025.
Abstract Background and aims The prevalence of metabolic dysfunction‐associated steatotic liver disease (MASLD) has increased during the epidemic of obesity. Type 2 diabetes mellitus (T2DM) is associated with progressive MASLD. Therefore, many guidelines recommend screening for MASLD in patients with T2DM.
Wile Balkhed, Martin Bergram, Fredrik Iredahl, Markus Holmberg, Carl Edin, Carl‐Johan Carlhäll, Tino Ebbers, Pontus Henriksson, Christian Simonsson, Karin Rådholm, Gunnar Cedersund, Mikael Forsgren, Olof Dahlqvist Leinhard, Cecilia Jönsson, Peter Lundberg, Stergios Kechagias, Nils Dahlström, Patrik Nasr, Mattias Ekstedt   +18 more
wiley   +1 more source

Detection of Pre–S1 Proteins in Serum and Liver of Hbsag–Positive Patients: A New Marker for Hepatitis B Virus Infection [PDF]

, 1986
Lorenz Theilmann, Mo‐Quen Klinkert, K. Gmelin, Jochen Salfeld, Heinz Schaller, Eberhard Pfaff   +5 more
openalex   +1 more source

Treatment Discontinuation and Adherence in Patients With Chronic Hepatitis B Infection Newly Initiating Nucleos(t)ide Analogues in Japan: A Retrospective Cohort Study

Journal of Viral Hepatitis, Volume 32, Issue 9, September 2025.
ABSTRACT Nucleos(t)ide analogue (NA) therapy is the current standard of care for chronic hepatitis B (CHB) virus infection but rarely achieves functional cure, necessitating long‐term therapy, which often leads to nonadherence and increased treatment burden.
Shinya Kawamatsu, Kiran K. Rai, Vera Gielen, Amisha Patel, Olivia Massey, Seth W. Anderson, Yutaka Handa, Ethan Yichen Lee, Poppy Payne, Isabel Jimenez, Kejsi Begaj, Shayon Salehi, Jun Inoue, Afisi S. Ismaila   +13 more
wiley   +1 more source

Geographic distribution of HBsAg subtypes in Brazil [PDF]

, 1987
Ana Maria Coimbra Gaspar, Clara Fumiko Tachibana Yoshida   +1 more
openalex   +1 more source

The Medical Impact of Hepatitis D Virus Infection in Natives and Immigrants: The Italian Paradigm

Liver International, Volume 45, Issue 9, September 2025.
ABSTRACT Background and Aim Ongoing migratory flows are reconstituting the hepatitis D virus (HDV) reservoir in Italy. We aimed to characterise the current clinical and virologic features of HDV infection in both native Italians and migrants. Methods We enrolled 515 hepatitis B surface antigen (HBsAg)‐positive patients with detectable anti‐HDV ...
Gian Paolo Caviglia, Eleonora Dileo, Antonella Olivero, Giulio Mengozzi, Alessia Ciancio, Alessandro Loglio, Mauro Viganò, Stefano Fagiuoli, Piero Colombatto, Barbara Coco, Maurizia Rossana Brunetto, Debora Angrisani, Alfonso Galeota Lanza, Carlo Magni, Giuliano Rizzardini, Vincenzo Messina, Michele Milella, Annalisa Saracino, Letizia Marinaro, Giuseppe Cariti, Valentina Cossiga, Filomena Morisco, Silvia Cretella, Gabriella Verucchi, Elisa Biliotti, Giampiero D'Offizi, Marcello Feasi, Emanuele Pontali, Carmine Coppola, Rachele Rapetti, Mario Pirisi, Antonio Izzi, Teresa Santantonio, Vito Di Marco, Aldo Marrone, Nicola Coppola, Marco Rizzi, Anna Maria Cattelan, Grazia Anna Niro, Pierluigi Toniutto, Francesca Romana Ponziani, Luca Saverio Belli, Alessandro Federico, Gaetano Bertino, Michele Barone, Massimo Puoti, Alberto Civolani, Marco Distefano, Lorenzo Antonio Surace, Raffaele Cozzolongo, Ester Marina Cela, Elisabetta Teti, Pietro Lampertico, Tommaso Stroffolini, Mario Rizzetto, on behalf of the HDV Describe Study Group, Alessandra Risso, Yulia Troshina, Giorgio Maria Saracco, Tilde Manetta, Barbara Donati Marello, Paola Merlach, Elisa Farina, Giovan Giuseppe Di Costanzo, Raffaella Tortora, Spinello Antinori, Matilde Quaranta, Silvia Taurian, Caterina Quarta, Annarosa Garbuglia, Nicolina Capoluongo, Alessandro Perrella, Nunzia Cuomo, Francesco Tortorici, Emanuele Bracciamà, Clelia Cosentino, Mariantonietta Pisaturo, Giuliana Cologni, Francesco Barbaro, Rosa Cotugno, Ezio Fornasiere, Maria Pallozzi, Raffaella Viganò, Marcello Dallio, Mario Romeo, Laura Rapisarda, Enrico Siciliano, Alfredo Risicato, Elisabetta Falbo, Massimo Andreoni, Maria Paola Anolli   +90 more
wiley   +1 more source

Longitudinal prospective study of the hepatitis B (HBsAg) carrier state

, 1978
S.V. Feinman, B. Berris, N. Cooter, Josiah Sinclair, Dominik Wróbel   +4 more
openalex   +1 more source